Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: A comparative approach to conventional DNA vaccine

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 440-444

  Hashemi, Hamidreza ^a   Bamdad, Taravat ^a   Jamali, Abbas ^a   Pouyanfard, Somayeh ^a   Mohammadi, Masoumeh Gorgian ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

BALB c mice; DNA vaccine; Filamentous phage; Glycoprotein D; HSV 1

Indexed keywords

BACTERIOPHAGE DNA; DNA VACCINE; GLYCOPROTEIN D; GRANZYME B; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE LAMBDA; BACTERIOPHAGE M13; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE CASSETTE; GENETIC IMMUNIZATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS ENTRY;

ANIMALS; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENETIC VECTORS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; INOVIRUS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

ENTEROBACTERIA PHAGE LAMBDA; FILAMENTOUS BACTERIOPHAGE; HUMAN HERPESVIRUS 1; MAMMALIA; MUS;

EID: 73049087398     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.11.008     Document Type: Article

References (28)

1. Baghian A., Chouljenko V.N., Dauvergne O., Newmant M.J., Baghian S., and Kousoulas K.G. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with Herpes Simplex Virus type-1 genes specifying glycoproteins gB and gD. J. Med. Microbiol. 51 (2002) 350-357
2. Barouch D.H., Santra S., Tenner-Racz K., Racz P., Kuroda M.J., Schmitz J.E., Jackson S.S., Lifton M.A., Freed D.C., Perry H.C., Davies M.E., Shiver J.W., and Letvin N.L. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168 (2002) 562-568
3. Benhar I. Biotechnological applications of phage and cell display. Biotechnol. Adv. 19 (2001) 1-33
4. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., and Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3 (1997) 526-532
5. Buchwald U.K., Lees A., Steinitz M., and Pirofski L.A. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect. Immun. 73 (2005) 325-333
6. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., and Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160 (1998) 1320-1329
7. Clark J.R., and March J.B. Bacterial viruses as human vaccines?. Expert Rev. Vaccines 3 (2004) 463-476
8. Clark J.R., and March J.B. Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol. Med. Microbiol. 40 (2004) 21-26
9. Clark J.R., and March J.B. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol. 24 (2006) 212-218
10. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 175 (2005) 633-639
11. Ewen C., Kane K.P., Shostak I., Griebel P.J., Bertram E.M., Watts T.H., Bleackley R.C., and McElhaney J.E. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J. Immunol. Methods 276 (2003) 89-101
12. Ewen C.L., Rong J., Kokaji A.I., Bleackley R.C., and Kane K.P. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay. J. Immunol. Methods 308 (2006) 156-166
13. Frye T.D., Chiou H.C., Hull B.E., and Bigley N.J. The efficacy of a DNA vaccine encoding Herpes Simplex Virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge. Arch. Virol. 147 (2002) 1747-1759
14. Jiang W., Jin N., Cui S., Li Z., Zhang L., Wang H., and Han W. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector. J. Virol. Methods 136 (2006) 1-7
15. Kuklin N., Daheshia M., Karem K., Manickan E., and Rouse B.T. Induction of mucosal immunity against Herpes Simplex Virus by plasmid DNA immunization. J. Virol. 71 (1997) 3138-3145
16. Larralde O.G., Martinez R., Camacho F., Amin N., Aguilar A., Talavera A., Stott D.I., and Perez E.M. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity. J. Virol. Methods 140 (2007) 49-58
17. Manoutcharian K., Diaz-Orea A., Gevorkian G., Fragoso G., Acero G., Gonzalez E., De Aluja A., Villalobos N., Gomez-Conde E., and Sciutto E. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet. Immunol. Immunopathol. 99 (2004) 11-24
18. March J.B., Clark J.R., and Jepson C.D. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles. Vaccine 22 (2004) 1666-1671
19. Park I., Choi I.H., Kim S.J., and Shin J.S. Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide. Yonsei Med. J. 45 (2004) 755-758
20. Rininsland F.H., Helms T., Asaad R.J., Boehm B.O., and Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J. Immunol. Methods 240 (2000) 143-155
21. Sambrook J., and Russell D.W. Molecular Cloning, A Laboratory Manual (2001), Cold Spring Harbor Laboratory press
22. Soleimanjahi H., Roostaee M.H., Rasaee M.J., Mahboudi F., Kazemnejad A., Bamdad T., and Zandi K. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections. FEMS Immunol. Med. Microbiol. 46 (2006) 100-106
23. Spear P.G., Manoj S., Yoon M., Jogger C.R., Zago A., and Myscofski D. Different receptors binding to distinct interfaces on Herpes Simplex Virus gD can trigger events leading to cell fusion and viral entry. Virology 344 (2006) 17-24
24. Stephenson F.H. Calculations in Molecular Biology and Biotechnology (2003), Academic press
25. Tang M., Wang H., Zhou S., and Tian G. Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2. J. Virol. Methods 149 (2008) 42-48
26. Wilkinson R.A., Evans J.R., Jacobs J.M., Slunaker D., Pincus S.H., Pinter A., Parkos C.A., Burritt J.B., and Teintze M. Peptides selected from a phage display library with an HIV-neutralizing antibody elicit antibodies to HIV gp120 in rabbits, but not to the same epitope. AIDS Res. Hum. Retroviruses 23 (2007) 1416-1427
27. Wu Y., Wan Y., Bian J., Zhao J., Jia Z., Zhou L., Zhou W., and Tan Y. Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model. Int. J. Cancer 98 (2002) 748-753
28. Zhang Y., Jiang W., Fan Y., Wen J., Hao W., and Qian M. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. J. Virol. Methods 153 (2008) 142-148